| P50 | author | Harsha Thirumurthy | Q47498762 |
| P2093 | author name string | Viviane D Lima | |
| | James G Kahn | |
| | Alan Whiteside | |
| | Jorge Saavedra | |
| | Carlos F Cárceres | |
| P2860 | cites work | Putting risk compensation to rest: reframing the relationship between risk behavior and antiretroviral therapy among injection drug users | Q42410252 |
| | Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic | Q43598380 |
| | Towards an improved investment approach for an effective response to HIV/AIDS. | Q44667685 |
| | Epidemiological parameters of HIV transmission | Q44811069 |
| | The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models | Q46193879 |
| | Epidemiology of Antiretroviral Multiclass Resistance | Q57259606 |
| | Comparison of sexual behaviors, unprotected sex, and substance use between two independent cohorts of gay and bisexual men | Q57259787 |
| | Two-year impacts on employment and income among adults receiving antiretroviral therapy in Tamil Nadu, India: a cohort study | Q82849733 |
| | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
| | Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach | Q26859055 |
| | Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 |
| | A test of financial incentives to improve warfarin adherence | Q33395146 |
| | A tale of two futures: HIV and antiretroviral therapy in San Francisco. | Q33887969 |
| | Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya | Q34107939 |
| | Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. | Q34289633 |
| | HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa | Q34339465 |
| | HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making | Q34339523 |
| | The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic | Q34554572 |
| | The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection | Q35019915 |
| | Modelling the impact of antiretroviral therapy on the epidemic of HIV | Q36486234 |
| | The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men | Q36627938 |
| | Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa | Q36849824 |
| | Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda | Q37259148 |
| | Treatment as prevention: translating efficacy trial results to population effectiveness | Q37976999 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| P304 | page(s) | S16-20 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Modeling scenarios for the end of AIDS | |
| P478 | volume | 59 Suppl 1 | |